Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TXG · against 181 other Healthcare companies of similar size
Ranked #149 of 182 · scores higher than 1% of peers
Bars: peers in each 10-point band of the valuation score34 peers with a valuation score of 0–9, including TXG · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | TXG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 181 reported | -0.9% | 2.6% | 25% | 30% | |
| EBITDA yieldHigher is better · 180 reported | -0.5% | 4.8% | 18% | 50% | |
| Free cash flow yieldHigher is better · 108 reported | 1.4% | 1.8% | 47% | 20% | |
| Book yieldHigher is better · 181 reported | 9.7% | 19.9% | 24% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 5 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 149 | 12.6B USD | 8 | ||
| 149 | 5.4B USD | 8 | 24 | |
| 149 | 14.0B USD | 8 | 31 | |
| 149 | 9.3B USD | 8 | 29 | |
| 149 | 8.5B USD | 8 | 28 | |
| 181 | 34.9B CNY (≈$4.9B) | 0 | 16 | |
| 181 | 31.0B CNY (≈$4.3B) | 0 | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score